Professor of Dermatology, Boston University
Dermatology
Dr. Barbara A. Gilchrest, MD
|
|
Give Review
Barbara Gilchrest practices Dermatology. He attended Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School has a rank of 1 in research and a 12 in primary care He received 7 awards: "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Boston Herald", "Elected Member", "Whos Who in Medicine and Healthcare" and "Super Doctor". Barbara A. Gilchrest, MD is a published doctor as well. He has 73 publications published. The latest was: The role of vitamin D in melanoma prevention: Evidence and hyperbole. Barbara A. Gilchrest accepts Medicare.
Publications
- The role of vitamin D in melanoma prevention: Evidence and hyperbole.
- Effective blue light photodynamic therapy does not affect cutaneous langerhans Cell number or oxidatively damage DNA.
- Collagenase Followed by Compression for the Treatment of Earlobe Keloids.
- JAAD Grand Rounds quiz: Nail dystrophy and multiple hyperkeratotic papules on the face and neck.
- Topical Application of Thymidine Dinucleotide to Newborn Mice Reduces and Delays Development of UV-Induced Melanomas.
- Acute New World cutaneous leishmaniasis presenting as tuberculoid granulomatous Dermatitis.
- Ultraviolet-Fluorescent Tattoo Location of Cutaneous Biopsy Site.
- Iatrogenic effects of photoprotection recommendations on Skin cancer development, vitamin D levels, and general health.
- Molecular aspects of tanning.
- Radiosensitization of mammary carcinoma Cells by telomere homolog oligonucleotide pretreatment.
- What is all this commotion about vitamin D?
- Photodynamic therapy for patients with Basal cell nevus syndrome.
- Telomere-mediated effects on melanogenesis and Skin aging.
- Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid Cells: mechanism and therapeutic potential.
- p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation.
- Sun exposure and vitamin D sufficiency.
- Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced Basal cell carcinoma in Ptch-1+/- mice.
- Photoprotection in human Skin--a multifaceted SOS response.
- Quantification of inducible SOS-like photoprotective responses in human Skin.
- Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma Cells.
- Photosensitivity Dermatitis from inadvertent exposure to aminolevulinic acid.
- Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer Cells.
- Academic dermatology manpower: issues of recruitment and retention.
- Visual screening for malignant melanoma: a cost-effectiveness analysis.
- A role for WRN in telomere-based DNA damage responses.
- Bone morphogenetic protein-4, a novel modulator of melanogenesis.
- T-oligos augment UV-induced protective responses in human Skin.
- A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.
- Obstacles to translation conference.
- Skin cancer examination teaching in US medical education.
- A call for the development and implementation of a targeted national melanoma screening program.
- Improving Skin cancer prevention and detection education in US medical schools.
- Detection of UV-induced pigmentary and epidermal changes over time using in vivo reflectance confocal microscopy.
- The vitamin D questions: how much do you need and how should you get it?
- Broad area photodynamic therapy for treatment of multiple Basal cell carcinomas in a patient with nevoid Basal cell carcinoma syndrome.
- The tale of the telomere: implications for prevention and treatment of Skin cancers.
- Psychosocial aspects of aging Skin.
- T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter.
- Sunlight, tanning booths, and vitamin D.
- Bone morphogenetic protein (BMP) signaling controls Hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway.
- Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides.
- Telomere-based DNA damage responses: a new approach to melanoma.
- Fas signaling is involved in the control of Hair follicle response to chemotherapy.
- If it's not the hamburgers, it's the sunscreens.
- delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple Basal cell carcinomas in two patients with nevoid Basal cell carcinoma syndrome.
- Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in Hairless mice.
- Melanocyte biology: before, during, and after the Fitzpatrick era.
- A trial of short incubation, broad-area photodynamic therapy for facial Actinic keratoses and diffuse photodamage.
- Topical application of a protein kinase C inhibitor reduces Skin and hair pigmentation.
- The interdependence of Skin aging, Skin cancer, and DNA repair capacity: a novel perspective with therapeutic implications.
- Skin cancer prevention and detection practices among siblings of patients with melanoma.
- Skin aging 2003: recent advances and current concepts.
- Topical photodynamic therapy: a new tool in cosmetic dermatology.
- Fate of melanocytes during development of the Hair follicle pigmentary unit.
- UV induces VEGF through a TNF-alpha independent pathway.
- Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA.
- Evidence that exposure of the telomere 3' overhang sequence induces senescence.
- The first 15 years of the American Academy of Dermatology Skin cancer screening programs: 1985-1999.
- Fas and c-kit are involved in the control of Hair follicle melanocyte apoptosis and migration in chemotherapy-induced Hair loss.
- p75 Neurotrophin receptor antagonist retards apoptosis-driven Hair follicle involution (catagen).
- More on MITF.
- Fifty years of Skin aging.
- The demographics of aging in the United States: implications for dermatology.
- Effect of sunscreen application on UV-induced thymine dimers.
- Melanoma incidence and mortality among US whites, 1969-1999.
- Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreen...
- Should the Skin cancer examination be taught in medical school?
- Induction of apoptosis by telomere 3' overhang-specific DNA.
- DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity.
- Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling.
- Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) Hair follicles.
- Tyrosinase gene expression is regulated by p53.
Schools
Harvard Medical School
Boston City Hospital
Harvard University
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Shaving of Skin Lesion
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
- Internal Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Fallon Community Health Plan
- Guardian
- Harvard Pilgrim Health Care PPO
- Medicare Advantage PFFS
- Kaiser Permanente
- Medicaid
- Medicare MCR
- Neighborhood Health Plan
- Simplifi
- Tufts Health Plans
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Boston Herald
- Elected Member
- Whos Who in Medicine and Healthcare
- Super Doctor
Education
-
Massachusetts General Hospital -
Boston University Medical Center -
Harvard Medical School
Hospital
-
Boston Medical Center
Drug Facts
| NPI NUMBER | 1831180868 | |
| NPPES Provider LastName | GILCHREST | |
| NPPES Provider FirstName | BARBARA | |
| NPPES Provider ZIPCode | 021182526 | |
| NPPES Provider State | MA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 43.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831180868 |
| Last Name Of The Provider | GILCHREST |
| First Name Of The Provider | BARBARA |
| View All |
Similar Doctors
|
|
Dr. Aieska De Souza, MD |
|
|
Dr. Danielle Molofsky Levine, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sabina Bis, MD |
|
|
Dr. Whitney L. Tolpinrud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francisco Ramirez-Valle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katayun S. Adhami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yiyin E. Chen, MD |
|
|
Dr. Alexandra B. Kimball, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer T. Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina Lam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca B. Campen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Sherling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul C. Levins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph F. Merola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan E. Moran, MD |
|
|
Dr. Pushkal P. Garg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vladimir Kaplinskiy, MD |
|
|
Dr. Jorge Barrero, MD |
|
|
Dr. Rebecca R. Saff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert L. Sheffer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel J. Stadecker, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sarah J. Hahn, MD |